NCT06550856 SUTURE-CLOSURE OMENTOPEXY VERSUS OMENTOPEXY ALONE IN REPAIR OF PERFORATED PEPTIC ULCER
| NCT ID | NCT06550856 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Perforated Peptic Ulcer |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-07-15 |
| Primary Completion | 2025-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-07-15 with a primary completion date of 2025-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The present study will be conducted to assess whether there is a direct benefit associated with modified-Graham's omentopexy (MGO), above and beyond the benefit associated with Graham's omentopexy (GO) in the treatment of perforated duodenal ulcers. We attempted to answer the question whether primary closure of the perforation in MGO will affect the outcome of surgery. Complication rates will be compared for the two alternative surgical procedures.
Eligibility Criteria
Inclusion Criteria: \- All adult patients of both sexes with a clinical diagnosis of perforated peptic ulcer (gastric or duodenal) that are fit to undergo surgery. Exclusion Criteria: \- 1. Patients with associated bleeding ulcer (additional steps are needed to control bleeding). 2\. Patients with associated pathology other than perforated peptic ulcer that needs surgical intervention.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06550856 clinical trial?
This trial is open to participants of all sexes, studying Perforated Peptic Ulcer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06550856 currently recruiting?
Yes, NCT06550856 is actively recruiting participants. Contact the research team at adelosman3399@gmail.com for enrollment information.
Where is the NCT06550856 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT06550856 clinical trial?
NCT06550856 is sponsored by Sohag University. The trial plans to enroll 50 participants.